Literature DB >> 17879383

Pathological correlates of dementia in a longitudinal, population-based sample of aging.

Joshua A Sonnen1, Eric B Larson, Paul K Crane, Sebastien Haneuse, Ge Li, Gerald D Schellenberg, Suzanne Craft, James B Leverenz, Thomas J Montine.   

Abstract

OBJECTIVE: Previously published community- or population-based studies of brain aging and dementia with autopsy were restricted to a single sex, a single ethnic group, Roman Catholic clergy, or focused pathological assessments. Our goal was to determine the independent pathological correlates associated with dementia in a typical US population.
METHODS: We evaluated autopsy data from the Adult Changes in Thought study, an ongoing longitudinal, population-based study of brain aging and dementia. Analyses were based on data collected from about 3,400 people 65 years or older who were cognitively intact at the time of enrollment in the Group Health Cooperative in King County, Washington. All consecutive autopsies (n = 221; 20% of deaths) from this cohort were evaluated and analyzed by weighted multivariate analysis to account for potential participation bias.
RESULTS: After adjusting for age, sex, education, and APOE, independent correlates of dementia (relative risk, 95% confidence interval; overall p value) included Braak stage (V/VI vs 0/I/II: 5.89, 1.62-17.60; p < 0.05), number of cerebral microinfarcts in standardized sections (>2 vs none: 4.80, 1.91-10.26; p < 0.001), and neocortical Lewy bodies (any vs none: 5.08, 1.37-18.96; p < 0.05). Estimates of adjusted population attributable risk for these three processes were 45% for Braak stage, 33% for microinfarcts, and 10% for neocortical Lewy bodies.
INTERPRETATION: Our results underscore the therapeutic imperative for Alzheimer's and Lewy body diseases, and provide evidence to support the immediate use of strategies that target cerebral microinfarcts as a means to partially prevent or delay the onset of dementia.

Entities:  

Mesh:

Year:  2007        PMID: 17879383     DOI: 10.1002/ana.21208

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  223 in total

1.  Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.

Authors:  Karen S SantaCruz; Joshua A Sonnen; Maryam Kherad Pezhouh; Mark F Desrosiers; Peter T Nelson; Suzanne L Tyas
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

2.  Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

Authors:  John L Robinson; Felix Geser; Maria M Corrada; Daniel J Berlau; Steven E Arnold; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

3.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

4.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

Review 5.  Cerebral microinfarcts: the invisible lesions.

Authors:  Eric E Smith; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

6.  Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.

Authors:  C Dirk Keene; Rubens C Chang; Americo H Lopez-Yglesias; Bryan R Shalloway; Izabella Sokal; Xianwu Li; Patrick J Reed; Lisa M Keene; Kathleen S Montine; Richard M Breyer; Jason K Rockhill; Thomas J Montine
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

Review 7.  Profile of cognitive impairment in Parkinson's disease.

Authors:  G Stennis Watson; James B Leverenz
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 8.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 9.  Prospects for delaying the rising tide of worldwide, late-life dementias.

Authors:  Eric B Larson
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

10.  Adjustment for selection bias in observational studies with application to the analysis of autopsy data.

Authors:  S Haneuse; J Schildcrout; P Crane; J Sonnen; J Breitner; E Larson
Journal:  Neuroepidemiology       Date:  2009-01-29       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.